Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21.95M P/E - EPS this Y - Ern Qtrly Grth -
Income -6.28M Forward P/E 10.57 EPS next Y - 50D Avg Chg -6.00%
Sales 39.55M PEG - EPS past 5Y -47.96% 200D Avg Chg -28.00%
Dividend N/A Price/Book 0.59 EPS next 5Y 30.00% 52W High Chg -49.00%
Recommedations 3.00 Quick Ratio 1.00 Shares Outstanding 14.18M 52W Low Chg 3.00%
Insider Own 44.06% ROA -4.44% Shares Float 8.02M Beta 0.17
Inst Own 15.57% ROE -19.41% Shares Shorted/Prior 17.31K/20.44K Price 1.48
Gross Margin 84.66% Profit Margin -15.88% Avg. Volume 32,466 Target Price -
Oper. Margin -30.32% Earnings Date May 7 Volume 4,352 Change 2.07%
About Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Cumberland Pharmaceuticals Inc. News
04/30/24 CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
04/02/24 NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
03/07/24 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
03/07/24 Cumberland Pharmaceuticals Full Year 2023 Earnings: US$0.44 loss per share (vs US$0.38 loss in FY 2022)
03/06/24 Q4 2023 Cumberland Pharmaceuticals Inc Earnings Call
03/05/24 Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
02/27/24 CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
11/12/23 Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
11/07/23 Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
10/31/23 CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
10/10/23 NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE
08/08/23 Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
08/01/23 CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS
06/26/23 NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS
05/31/23 CPIX: A Solid Stock with an Exciting Catalyst
05/23/23 CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
05/15/23 CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTS
05/09/23 Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update
CPIX Chatroom

User Image Stock_Titan Posted - 04/30/24

$CPIX CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS https://www.stocktitan.net/news/CPIX/cumberland-pharmaceuticals-to-announce-first-quarter-2024-financial-hpsev0vojkbm.html

User Image fda_tracker Posted - 04/11/24

$CPIX Phase 2 trial w/est Apr completion date NCT03028350: https://www.clinicaltrials.gov/study/NCT03028350 Trial Tracker: https://www.fdatracker.com/trial-tracker/

User Image Stock_Titan Posted - 1 month ago

$CPIX NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS https://www.stocktitan.net/news/CPIX/new-report-supports-use-of-caldolor-r-as-a-standard-of-care-across-vwsx6ynm5mg2.html

User Image veryboredXYZ Posted - 1 month ago

$CPIX Imma Open a position here again. Took the sweet 20% beforehand but I think we upto something.

User Image WesleyVanguard3 Posted - 03/28/24

$CPIX I am still bullish on this stock. Not sure why it's stalling but I believe 👍🏻💯✔️

User Image swingingtech Posted - 03/06/24

$CPIX https://wallstreetwaves.com/cpix-stock-earnings-cumberland-reported-results-for-q4-2023/

User Image Stock_Titan Posted - 03/05/24

$CPIX Cumberland Pharmaceuticals Reports Annual 2023 Financial Results https://www.stocktitan.net/news/CPIX/cumberland-pharmaceuticals-reports-annual-2023-financial-zkj0oj6dpv6b.html

User Image Stock_Titan Posted - 02/27/24

$CPIX CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS https://www.stocktitan.net/news/CPIX/cumberland-pharmaceuticals-to-announce-annual-2023-financial-ia1u8a7njkv0.html

User Image Stocks4thought Posted - 02/23/24

$CPIX Readying (nobody valuing PHII assets).

User Image ChiefOG Posted - 02/22/24

$CPIX 🧐

User Image Siuolman58 Posted - 01/26/24

$CPIX This is starting to rev up!

User Image tickeron Posted - 01/18/24

How does this make you feel? $CPIX MACD Histogram turned negative on January 17, 2024. View odds of downtrend. https://srnk.us/go/4972535

User Image StockAutomatePro Posted - 01/06/24

$CPIX Good news for investors chart analysis shows upward momentum. We alerted the BUY signal at $1.86 and we were able to close this one with profit at $2.24 💖

User Image buymoremakemore Posted - 01/05/24

$CPIX wow larger than usual volume today

User Image fda_tracker Posted - 01/05/24

$CPIX Phase 2 trial w/est Jan completion date NCT03694249: https://www.clinicaltrials.gov/study/NCT03694249 Trial Tracker: https://www.fdatracker.com/trial-tracker/

User Image dividendinvestorbyeagle Posted - 01/04/24

$CPIX close increased > 10% (Cumberland Pharmaceuticals Inc) https://www.dividendinvestor.com/dividend-news/?symbol=cpix http://dlvr.it/T0zF1g

User Image SheriFlaherty Posted - 01/04/24

$NEUE $CPIX $CMCT ACCOUNT CHALLENGE UPDATE: Starting Balance: $3,700 Current Balance: $54,873 Goal: $100K by end of Jan. Watch out for our next alert!':''.'''👓 stocks-live-trading-realtime-chat-us.blogspot.com/2023/12/blog-post.html

User Image buymoremakemore Posted - 4 months ago

$CPIX my hopes for Cumberland this year is a jump in price from various phase 2 results for ifetroban and steady increase in quarterly earnings, positive broader market sentiment boost, etc. My concern is that this year they might secure some dilutive funding, as evident in the shelf offering they filed in December. That might increase outstanding shares from 14 to > 50 million shares. But perhaps the dilution could be for the better if they have big plans that we dont know about.

User Image tickeron Posted - 12/31/23

Good move or bad move? $CPIX price exceeded its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4956031

User Image tickeron Posted - 12/29/23

Oh wow this is big! $CPIX Stochastic Oscillator left the oversold zone. View odds of downtrend. https://srnk.us/go/4954726

User Image cctranscripts Posted - 12/28/23

Cumberland Pharmaceuticals Inc. insider just picked up 1,174 shares https://www.conferencecalltranscripts.org/summary/?id=12827284 $CPIX

User Image cctranscripts Posted - 12/28/23

Cumberland Pharmaceuticals Inc. insider just picked up 6,407 shares https://www.conferencecalltranscripts.org/summary/?id=12827309 $CPIX

User Image cctranscripts Posted - 12/27/23

Notice of Effectiveness https://www.conferencecalltranscripts.org/summary/?id=12822651 $CPIX

User Image Invest2live Posted - 12/26/23

$CPIX strong fundamentals; do your DD and get some.

User Image tickeron Posted - 12/24/23

How does this affect your portfolio? $CPIX entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4949846

User Image Invest2live Posted - 12/22/23

$ATUS 13% already. Check out; stocks with similar or greater potential. $CME low dept and can reach 230 soon $SCYX strong fundamentals; 2+ coming $CPIX great value stock $EOG Great value All the best. Share your favorites. Have a good day.

User Image Invest2live Posted - 12/21/23

$CPIX and $SCYX excellent value; do your DD and get in.

User Image Invest2live Posted - 12/20/23

$CPIX strong fundamentals; cheap shares now. For longs.

User Image tickeron Posted - 12/19/23

What do you think of this? $CPIX Stochastic Oscillator left the oversold zone. View odds of downtrend. https://srnk.us/go/4945557

User Image MarketBeat Posted - 12/18/23

Cumberland Pharmaceuticals initiated by StockNews.com at hold. www.marketbeat.com/stocks/NASDAQ/CPIX/price-target/ $CPIX

Analyst Ratings
B. Riley Securities Buy Dec 3, 19
B. Riley Securities Buy Nov 18, 19
B. Riley Securities Buy Aug 17, 18
B. Riley Securities Buy Apr 17, 18
UBS Neutral Apr 10, 13
UBS Neutral Nov 12, 12
Wells Fargo Market Perform Nov 9, 12
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Young Caroline Director Director Dec 01 Buy 2.22 379 841 19,587 12/23/22
Jones James Director Director Dec 01 Buy 2.22 667 1,481 26,293 12/23/22
Galante Joseph C Director Director Dec 01 Buy 2.22 1,550 3,441 57,356 12/23/22
Krogulski Kenneth Director Director Dec 01 Buy 2.22 3,050 6,771 204,955 12/23/22
Young Caroline Director Director Nov 01 Buy 2.37 420 995 19,208 12/23/22
Jones James Director Director Nov 01 Buy 2.37 651 1,543 25,626 12/23/22
Galante Joseph C Director Director Nov 01 Buy 2.37 1,365 3,235 55,806 12/23/22
Krogulski Kenneth Director Director Nov 01 Buy 2.37 2,205 5,226 201,905 12/23/22
Young Caroline Director Director Jul 01 Buy 2.32 678 1,573 17,682 08/19/22
Jones James Director Director Jul 01 Buy 2.32 1,057 2,452 23,255 08/19/22
Galante Joseph C Director Director Jul 01 Buy 2.32 2,125 4,930 50,891 08/19/22
Krogulski Kenneth Director Director Jul 01 Buy 2.32 3,566 8,273 193,900 08/19/22
Young Caroline Director Director May 02 Buy 2.31 480 1,109 16,471 06/10/22
Jones James Director Director May 02 Buy 2.31 718 1,659 21,401 06/10/22
Galante Joseph C Director Director May 02 Buy 2.31 1,441 3,329 47,143 06/10/22
Krogulski Kenneth Director Director May 02 Buy 2.31 2,407 5,560 187,617 06/10/22
Young Caroline Director Director Apr 14 Buy 2.61 214 559 15,991 05/06/22
Jones James Director Director Apr 14 Buy 2.61 318 830 20,683 05/06/22
Galante Joseph C Director Director Apr 14 Buy 2.61 641 1,673 45,702 05/06/22
Krogulski Kenneth Director Director Apr 14 Buy 2.61 1,069 2,790 185,210 05/06/22
Jones James Director Director Dec 01 Buy 4.66 423 1,971 19,365 01/07/22
Young Caroline Director Director Dec 01 Buy 4.66 394 1,836 14,777 01/07/22
KAZIMI A J Chairman and CEO Chairman and CEO Dec 01 Buy 4.66 394 1,836 5,770,563 01/07/22
Krogulski Kenneth Director Director Dec 01 Buy 4.66 1,956 9,115 183,141 01/07/22
Galante Joseph C Director Director Oct 01 Buy 2.72 2,982 8,111 43,777 11/05/21
Jones James Director Director Oct 01 Buy 2.72 882 2,399 18,060 11/05/21
Young Caroline Director Director Sep 01 Buy 2.72 315 857 13,988 11/05/21